EMERGING MARKETS - Fundamentally weighted indices perform better in emerging markets than capitalisation weighted indices, according to Research Affiliates chief investment officer Jason Hsu.
The fundamentally weighted FTSE RAFI Emerging Market (EM) index has produced a 6.5% outperformance per annum against the MSCI EM index in the last five years, according to Hsu.
He said the fundamental methodology thrives on market price inefficiencies, whereas the capitalisation weighted indices typically give greater exposure to the more over-valued stocks.
Hsu explained the influence of price has gone with fundamental indices, and there is no correlation between weights and the random mistakes prices can make.
He added: "In emerging markets, where miss-valuation is the greatest, it is essential to break the price link with the index portfolio weights."
Fundamental indices also preserve liquidity as they take into account weighting metrics that are generally related to the investment capacity of the stock. Hsu said: "These weighting metrics are also specifically chosen and designed to not be correlated with prices and therefore price mistakes."
Nonetheless, there is a need for education as to how fundamental indices are constructed.
Tim Mitchell, head of listed fund sales at Invesco Perpetual, said: "These types of indices are more popular in the US, where indexation is more developed, but it's filtering over to Europe now. However, we are in an education game."
The Research Affiliates Fundamental Index (RAFI) strategy uses four metrics, to offer diversification and level the biases associated with any particular metric. Hsu said mainstream accounting variables are used, where the level of data quality is high.
The Next Generation Pensions Committee is on a mission to promote and encourage younger voices in the industry. Kim Kaveh looks at its key objectives
This week's top stories included an analysis finding the cost of equalising guaranteed minimum pensions in schemes could hit FTSE 100 profits by up to £15bn.
Employers whose dividend to deficit recovery contribution (DRCs) ratios fall outside the "normal range" should expect to see higher regulatory scrutiny, although no fixed ratio will be set.
Investment consultants and fiduciary managers should expect a final decision on the investigation into the market to be published by the end of the year, the competition watchdog says.